Delek US Holdings is poised to report its fourth-quarter earnings on February 27 before the market opens. Investors are particularly focused on revenue and profit margins, as fluctuations in the energy sector could significantly impact stock performance following the announcement.
Delek US Holdings has an RSI of 29.9, indicating it is oversold. JP Morgan lowered DK's price target from $42 to $38, maintaining 'Neutral' rating. DK's stock dropped 9% in the last month, with a 52-week low of $11.02. Shares closed at $29.01, down 3.8% on Thursday. Edge Stock Ratings shows DK with a momentum score of 71.40.
Delek US exceeded Q3 sales estimates at $2.887 billion. Adjusted earnings rose to $7.13 per share from a loss last year. EOP efforts enhance DK’s free cash flow significantly. Analysts raised price targets following earnings announcement. Delek US shares increased by 1.9% after results.
U.S. stocks saw significant gains after a rough week. Federal Reserve signals may influence rate cuts in 2025. Mixed economic data caused market volatility and cautious trading. Commodities like natural gas hit a new high due to winter demand.
Zacks Rank has outperformed the S&P 500 since 1988 with +24.15% annual gains. Zacks calculates monthly returns for stocks based on price and dividends. Independent research is emphasized to provide investors with a trading advantage.
- Novo Nordisk's obesity drug Wegovy approved in China, surging demand for similar treatments. - Volkswagen investing $1 billion in Rivian partnership, aiming to boost software unit. - FedEx ended losing streak with better-than-expected quarterly sales, restructuring efforts paying off. - Amazon hits $2 trillion valuation, adding another trillion in four years. - Walgreens closing poorly performing US stores, struggles financially, miss expectations. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Market Recap